KNOLL CAPITAL MANAGEMENT, LP Information

5 EAST 44TH STREET, NEW YORK, New York, 10017, (212) 808-7474

Report Date: 12/31/2014

Position Statistics

Total Positions 16
New Positions 1
Increased Positions 4
Decreased Positions 4
Positions with Activity 8
Sold Out Positions 2
Total Mkt Value (in $ millions) 311

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 96.53%
Services
Technology
Transportation
Utilities

16 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
MEDIVATION INC COM 263,798 New 2,244,519
AMPIO PHARMACEUTICALS INC COM 19,110 99 .52 3,388,322
SYNTHETIC BIOLOGICS INC COM 7,890 4,735 150.06 3,400,816
ALCOBRA LTD SHS 6,516 1,343 25.96 865,315
NEWLINK GENETICS CORP COM 3,336 New 77,437
KERYX BIOPHARMACEUTICALS INC COM 2,432 New 200,000
BIO BLAST PHARMA LTD SHS 2,292 New 338,110
ADVAXIS INC COM NEW 2,025 New 225,000
AUSPEX PHARMACEUTICALS INC COM 1,345 1,345 New 20,000
ADVAXIS INC WT EXP 071518 675 New 112,500
GALMED PHARMACEUTICALS LTD SHS 617 New 65,000
INOVIO PHARMACEUTICALS INC COM NEW 581 -142 (19.59) 82,088
PROVECTUS BIOPHARMACEUTICALS I COM 184 New 200,000
NEPHROGENEX INC COM 22 -342 (93.86) 3,072
CELLECTAR BIOSCIENCES INC COM NEW -41 Sold Out 0
NORTHWEST BIOTHERAPEUTICS INC COM PAR $0.001 -494 Sold Out 0


Latest News Headlines

View All
Create your free portfolio